During the past decade, dgd Research conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 18 clinical trials were completed, i.e. on average, 78.3% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "dgd Research" #1 sponsor was "Mannkind Corporation" with 12 trials, followed by "AstraZeneca" with 9 trials sponsored, "Shire" with 6 trials sponsored, "Medtronic Diabetes" with 5 trials sponsored and "DexCom, Inc." with 5 trials sponsored. Other sponsors include 65 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "dgd Research" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Jaeb Center for Health Research" with 2 trials as a collaborator, "Allied Research International" with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "dgd Research" are "Diabetes Mellitus, Type 2" (16 trials), "Diabetes Mellitus" (11 trials), "Type 2 Diabetes" (10 trials), "Type 2 Diabetes Mellitus" (8 trials) and "Diabetes Mellitus, Type 1" (7 trials). Many other conditions were trialed in "dgd Research" in a lesser frequency.

Most popular intervention types in "dgd Research" are "Drug" (84 trials), "Device" (16 trials), "Other" (6 trials), "Biological" (4 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "placebo" (6 trials), "AC2993" (4 trials), "Technosphere Insulin" (4 trials) and "Technosphere® Insulin Inhalation Powder" (3 trials). Other intervention names were less common.

The vast majority of trials in "dgd Research" are 99 trials for "All" genders, 4 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "dgd Research". undefined are not yet recruiting, 6 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in dgd Research, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in dgd Research, 11 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 15 trials that are defined as “Not Applicable".